Back to
Qube Research & Technologies Ltd
ARTV
3 quarters
Position history for
Qube Research & Technologies Ltd's holdings in ARTIVA BIOTHERAPEUTICS INC
No. Qube Research & Technologies exited its ARTV (Artiva Biotherapeutics) position in Q4 2025. Its Q3 2025 13F listed 25,552 shares worth $73,334. Qube Research & Technologies first reported ARTV in Q2 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$58,425
Total Shares Change
-38,692
Quarter-by-Quarter History